Blue Latitude Health’s consultancy is based on a rich vein of expert knowledge. Here you’ll find thought-provoking commentary, articles, and downloadable resources created by our consultants.
Explore our ideas and get a deeper understanding of the current and future trends in healthcare:
|20th May 2015
In this blog, Senior Consultant Craig Moore, from the Blue Latitude Health Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.
|18th May 2015
Recent research from the World Health Organisation and the Mayo Clinic on the impact of (and influences on) a patient’s ability to adhere to their treatment regime has shown that an astounding amount of patients do not follow or complete their treatment as prescribed. Head of Customer Experience Elisa del Galdo looks at the factors around patient non-adherence and how pharma can help to solve the problem.
|28th April 2015
Martine Leroy and Elisa del Galdo break down what customer experience research is, and why it’s important for pharma companies to employ it in the development of customer-centric products and services.
|30th March 2015
One of the predictions we made in early 2015 was around wearables: “Wearable tech will play an even more integral role in the collection of aggregated patient data to help identify disease trends, predict treatment outcomes and improve future diagnoses. What we anticipate seeing more of in 2015 is a closer integration between the wearable device and how it feeds information to various sources.”
Account Executive Stuart Goodman takes a look at this prediction and provides an analysis of where wearables are heading.
|19th March 2015
Following on from our Top 7 Trends in Pharma Marketing for 2015 post, it is clear that the pharma marketing trends we expect to transform the healthcare sector are easier said than done.
Aurélie Pols from Mind Your Privacy has written this guest blog to talk about the first steps you need to take when considering data privacy and security.
|12th March 2015
The modern pharmaceutical market can be saturated with competing products, from bio-similars, to same in-class, to alternative MoA treatments. Standing out from the crowd can be tough; innovative and patient serving methods of differentiation are hard to come by.
Consultant Mark Assenti talks through the use of biomarkers in pharma marketing and where it's headed in 2015.
|5th February 2015
Senior Associate Consultant Mette discusses the influence of the fast-moving consumer goods (FMCG) market, and how risk-sharing agreements and integrated care platforms are progressing in healthcare and pharma.